Yee Ling Wu Selected Research

Complement C4 (Complement Component 4)

1/2016	Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations.
1/2016	Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis.
7/2010	Assessment of complement C4 gene copy number using the paralog ratio test.
6/2007	Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yee Ling Wu Research Topics

Disease

10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 06/2007
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 08/2012
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019
1	Atherosclerosis 01/2019
1	Hypersensitivity (Allergy) 01/2017
1	Asthma (Bronchial Asthma) 01/2017
1	Infections 01/2016
1	Hemolytic Anemia 01/2016
1	Dermatomyositis (Dermatopolymyositis) 01/2016
1	Virus Diseases (Viral Diseases) 09/2014
1	Neoplasms (Cancer) 04/2013
1	Breast Neoplasms (Breast Cancer) 04/2013
1	Rheumatoid Arthritis 05/2012

Drug/Important Bio-Agent (IBA)

6	Complement System Proteins (Complement)IBA 11/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2007
4	Complement C4 (Complement Component 4)IBA 01/2016 - 06/2007
3	Complement C4bIBA 01/2021 - 05/2012
3	AntibodiesIBA 01/2016 - 09/2014
3	Complement C4aIBA 08/2012 - 01/2011
2	Immunoglobulin G (IgG)IBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 04/2013
1	HLA-DRB1*04 antigenIBA 01/2021
1	Codon (Codons)IBA 01/2021
1	Antiphospholipid AntibodiesIBA 01/2019
1	Atorvastatin (Lipitor)FDA Link 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2019
1	Complement Factor H (Factor H)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2017
1	AntigensIBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2016
1	Single-Stranded DNA (DNA, Single Stranded)IBA 09/2014
1	CytidineIBA 09/2014
1	UracilIBA 04/2013
1	NucleotidesIBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Blood Proteins (Serum Proteins)IBA 08/2012
1	Toll-Like Receptor 7IBA 09/2010
1	HLA-DRB1*03:01 antigenIBA 04/2009

Therapy/Procedure

1	Therapeutics 01/2019